CORECIVIC REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
CoreCivic, Inc. (CXW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 New Release Contact: Investors: Jeb Bachmann - Managing Director, Investor Relations - (615) 263-3024 Media: Steve Owen - Vice President, Communications - (615) 263-3107 C ORE C IVIC R EPORTS T HIRD Q UARTER 2026 F INANCIAL R ESULTS S TRONG F INANCIAL P ERFORMANCE P
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The earnings beat and aggressive capital return program could drive short‑term price appreciation, while the leadership transition adds a governance risk factor.
Market read
First‑report earnings with material financial metrics and a sizable share‑repurchase, offering a clear trading catalyst.
What to watch
Potential risks from litigation, policy changes on immigration detention, and high leverage despite debt repayment.
Strong financial performance propelled by facility sales and occupancy gains; $500 million accelerated share repurchase agreement amplifies per share growth.
Third-quarter revenue increased 28.2%, Adjusted Diluted EPS increased 104.2%, and Adjusted EBITDA increased 32.6%, driven by facility activations, higher federal and state populations, and the CSP acquisition. GAAP results were also substantially lifted by a $1,770.7 million gain on sale of real estate assets.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total revenue, three months ended September 30, 2026GAAP | $744.1M | – | 28.2% |
| Operating expenses, three months ended September 30, 2026GAAP | 586.9M | – | – |
| General and administrative expenses, three months ended September 30, 2026GAAP | 56.41M | – | – |
| Depreciation and amortization, three months ended September 30, 2026GAAP | 33.92M | – | – |
| Asset impairments, three months ended September 30, 2026GAAP | — | – | – |
| Interest expense, net, three months ended September 30, 2026GAAP | −7.02M | – | – |
| Expenses associated with debt repayments and refinancing transactions, three months ended September 30, 2026GAAP | −4.00M | – | – |
| Gain on sale of real estate assets, net, three months ended September 30, 2026GAAP | $1.77B | – | NM |
| Contingent consideration for acquisition of businesses, three months ended September 30, 2026GAAP | 22.13M | – | – |
| Income before income taxes, three months ended September 30, 2026GAAP | 1.85B | – | – |
| Income tax expense, three months ended September 30, 2026GAAP | −505.3M | – | – |
| Net income, three months ended September 30, 2026GAAP | $1.34B | – | NM |
| Basic earnings per share, three months ended September 30, 2026GAAP | $ 14.62 | – | – |
| Diluted EPS, three months ended September 30, 2026GAAP | $14.49 per diluted share | – | NM |
| Adjusted net income, three months ended September 30, 2026non-GAAP | $45.7M | – | – |
| Adjusted Diluted EPS, three months ended September 30, 2026non-GAAP | $0.49 per diluted share | – | 104.2% |
| EBITDA, three months ended September 30, 2026non-GAAP | $1.90B | – | – |
| Adjusted EBITDA, three months ended September 30, 2026non-GAAP | $117.8M | – | 32.6% |
| Funds From Operations, three months ended September 30, 2026non-GAAP | $78.3M | – | – |
| Funds From Operations per diluted share, three months ended September 30, 2026non-GAAP | $0.84 per diluted share | – | – |
| Normalized Funds From Operations, three months ended September 30, 2026non-GAAP | $69.9M | – | – |
| Normalized FFO per diluted share, three months ended September 30, 2026non-GAAP | $0.75 per diluted share | – | 56.3% |
| Residential segment operating margin, three months ended September 30, 2026other | 22.3% | – | relatively flat |
| Residential segment occupancy, three months ended September 30, 2026other | 84.0% | – | – |
| Residential facilities under activation net operating income, three months ended September 30, 2026other | $19.9M | – | – |
| CoreCivic Services segment net operating income, three months ended September 30, 2026other | $9.6M | – | – |
| Federal customers revenue increase, three months ended September 30, 2026other | $71.3M | – | 22.2% |
| Federal customers share of total revenue, three months ended September 30, 2026other | 53% | – | – |
| Total revenue, nine months ended September 30, 2026GAAP | $2.04B | – | – |
| Net income, nine months ended September 30, 2026GAAP | $1.42B | – | – |
| Diluted earnings per share, nine months ended September 30, 2026GAAP | $ 14.89 | – | – |
| Adjusted net income, nine months ended September 30, 2026non-GAAP | $123.0M | – | – |
| Adjusted Diluted EPS, nine months ended September 30, 2026non-GAAP | $ 1.29 | – | – |
| Adjusted EBITDA, nine months ended September 30, 2026non-GAAP | $337.3M | – | – |
Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.
Full Year 2026 outlook
- NoteNet income: $1.461 billion to $1.467 billion
- NoteAdjusted Net Income: $165.0 million to $171.0 million
- NoteDiluted EPS: $15.42 to $15.48
- NoteAdjusted Diluted EPS: $1.74 to $1.80
- NoteFFO per diluted share: $2.85 to $2.92
- NoteNormalized FFO per diluted share: $2.78 to $2.85
- NoteEBITDA: $2.221 billion to $2.224 billion
- NoteAdjusted EBITDA: $442.5 million to $445.5 million
- NoteMaintenance capital expenditures on real estate assets: $30.0 million to $35.0 million
- NoteMaintenance capital expenditures on other assets and information technology: $35.0 million to $40.0 million
- NoteOther capital investments: $12.0 million
- NoteCapital expenditures associated with previously idled facilities being activated and additional potential facility activations: $35.0 million to $40.0 million
Capital returns
- Entered into a $500 million Accelerated Share Repurchase Agreement.
- Made a payment of $500.0 million to the Dealer and received 12.4 million shares of common stock from the Dealer.
- On November 3, 2026, the BOD authorized an increase to its existing share repurchase program pursuant to which CoreCivic may purchase up to an additional $500.0 million of CoreCivic’s outstanding common stock.
- The aggregate authorization under CoreCivic’s repurchase program increased from $1.2 billion of CoreCivic’s outstanding common stock to $1.7 billion of CoreCivic’s outstanding common stock.
- $755.8 million of repurchase authorization was available under the share repurchase program, before any additional repurchase settlements occur under the ASR Agreement.
What drove it
- Increased demand from U.S. Immigration and Customs Enforcement, including higher utilization of recently activated facilities.
- New contract awards and activation of the West Tennessee Facility, California City Facility, Diamondback Facility, and Midwest Facility.
- Higher federal and state populations across the remaining Residential portfolio.
- Acquisition of Clinical Solutions Pharmacy on April 1, 2026.
- Lower interest expense, net, reflecting debt repayments and higher interest income on larger cash balances.
- A 13.8% reduction in weighted average diluted shares outstanding, primarily resulting from the $500.0 million ASR Agreement.
- The four facilities under activation are expected to generate total annual revenue of approximately $320.0 million once fully activated.
Concerns
- The four facilities under activation were not yet contributing at a fully activated margin percentage.
- General and administrative expenses increased due to higher incentive compensation, transitional expenses related to executive leadership changes, and expenditures in technology.
- ICE can terminate management contracts for non-appropriation of funds or for convenience, and the Company can provide no assurance that it will continue to manage the four sold facilities or that management-agreement terms will remain the same.
- Discussions with ICE regarding potential acquisitions of additional detention facilities are preliminary, and updated guidance does not include any potential additional facility sales.
- The Appleton Facility is expected to have an immaterial impact to earnings for the remainder of 2026 due to start-up activities and phased intake operations.
What to watch
- Modification of ICE management contracts following the sales of the California City, Otay Mesa, Appleton, and Midwest facilities.
- The pace of detainee intake at Appleton, where detainee receipts are expected to begin in the fourth quarter of 2026 and activation is estimated to be complete in the second quarter of 2027.
- Further utilization and margin progression at the four previously idle facilities under activation.
- Potential additional facility sales to ICE.
- Final settlement of the ASR Agreement, scheduled to occur prior to the end of the second quarter of 2027.
- Execution against full-year 2026 Adjusted Diluted EPS guidance of $1.74 to $1.80 and Adjusted EBITDA guidance of $442.5 million to $445.5 million.
Balance sheet and cash flow
- Cash and cash equivalents as of September 30, 2026: $ 547,229 (amounts in thousands); December 31, 2025: $ 97,929 (amounts in thousands).
- Total debt outstanding as of September 30, 2026: $629.6 million.
- Current portion of long-term debt as of September 30, 2026: 6,720 (amounts in thousands); long-term debt, net: 616,394 (amounts in thousands).
- Total assets as of September 30, 2026: $ 3,681,191 (amounts in thousands); total stockholders’ equity: 2,278,110 (amounts in thousands).
- Used a portion of facility-sale net proceeds to pay down all of the $270.0 million outstanding on the Revolving Credit Facility, the $100.0 million outstanding Incremental Term Loan, and the $107.8 million outstanding Initial Term Loan.
- Redeemed $238.5 million of 4.75% senior unsecured notes on August 12, 2026 for approximately $239.0 million, plus accrued and unpaid interest.
- Reported charges totaling $4.0 million associated with debt repayments.
- Net proceeds from the four facility sales were approximately $1.6 billion after federal and state income taxes of approximately $0.5 billion and transaction costs.
Analysis
CoreCivic reported a sharply stronger third quarter, with total revenue of $744.1 million, up 28.2% from the prior-year quarter. GAAP net income was $1,344.1 million and diluted EPS was $14.49, primarily reflecting a $1,770.7 million gain on sale of real estate assets. Excluding special items, Adjusted Net Income was $45.7 million and Adjusted Diluted EPS was $0.49, compared with $26.2 million and $0.24, respectively, in the third quarter of 2025. Adjusted EBITDA increased 32.6% to $117.8 million.
Operational demand was led by ICE-related activity and higher utilization of previously idle assets. Residential occupancy increased to 84.0% from 76.7%, while federal customers generated 53% of total revenue and their revenue increased $71.3 million, or 22.2%. The West Tennessee, California City, Diamondback and Midwest facilities generated $19.9 million of net operating income during the quarter, though management said they were still in various activation stages and had not reached fully activated margin percentages. Residential operating margin was relatively flat at 22.3% versus 22.5% in the prior-year quarter.
The Services segment benefited from the April 1, 2026 acquisition of Clinical Solutions Pharmacy. Segment net operating income rose to $9.6 million from $1.1 million, with the increase primarily attributable to CSP. The acquisition, facility activations, higher federal and state populations, lower net interest expense and lower diluted share count also supported non-GAAP earnings and FFO. Normalized FFO was $69.9 million, or $0.75 per diluted share, compared with $52.1 million, or $0.48 per diluted share.
Capital allocation was materially reshaped by the sales of four detention facilities to the federal government. The transactions generated $2.2 billion of gross proceeds, an aggregate gain of approximately $1.8 billion and approximately $1.6 billion of net proceeds after income taxes and transaction costs. The company repaid more than $700 million of debt, ended the period with total debt outstanding of $629.6 million, and paid $500.0 million under its ASR Agreement. The board subsequently expanded repurchase authorization by an additional $500.0 million, leaving $755.8 million available before further ASR settlement effects.
Full-year 2026 guidance was updated. The company lowered GAAP net income guidance to $1.461 billion to $1.467 billion and diluted EPS guidance to $15.42 to $15.48, while raising Adjusted Net Income to $165.0 million to $171.0 million, Adjusted Diluted EPS to $1.74 to $1.80, FFO per diluted share to $2.85 to $2.92, Normalized FFO per diluted share to $2.78 to $2.85, and Adjusted EBITDA to $442.5 million to $445.5 million. Guidance incorporates management's estimate of the ownership-change impact for the four sold facilities but excludes any potential additional facility sales to ICE.
Management, verbatim
We delivered strong financial results in a very active quarter, driven by increased demand for our services from U.S. Immigration and Customs Enforcement (ICE), including higher utilization of recently activated facilities, as well as the contribution from our acquisition of Clinical Solutions Pharmacy earlier this year.
Lucibeth Mayberry, President and Chief Executive Officer
The sale of four detention facilities to the federal government during the third quarter generated total gross proceeds of $2.2 billion and a $1.8 billion aggregate gain on sale of real estate assets.
Lucibeth Mayberry, President and Chief Executive Officer
Our balance sheet has improved meaningfully and provides us significant flexibility with both our capital allocation strategy and growth plans.
Lucibeth Mayberry, President and Chief Executive Officer
Not in the filing
stated, not guessed- Segment revenue for CoreCivic Residential, CoreCivic Services, and CoreCivic Properties was not reported in the provided filing text.
- Gross margin was not reported.
- GAAP operating income was not reported.
- Operating cash flow was not reported.
- Free cash flow was not reported.
- Dividend payments or dividend guidance were not reported.
- Prior-quarter comparisons for the reported third-quarter metrics were not reported.
- A separate previous-release outlook section was not provided; therefore, no actual-versus-prior-guidance comparison has been made.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
CoreCivic filed an 8‑K reporting its third‑quarter 2026 financial results, including a $2.2 B facility sale and a $500 M share‑repurchase agreement.
Ticker impact
CoreCivic reported Q3 2026 net income of $1.344 billion and diluted EPS of $14.49, a massive increase year‑over‑year.
likely upward pressure as the market prices in the earnings beat and share‑repurchase program.
The earnings beat and $500 M accelerated share repurchase are new, material information for a mid‑cap listed issuer.
Market effects
Highlights strength in the private‑prison and detention‑facility sector, potentially boosting peers.
Positive for U.S. correctional‑services stocks and related REITs.
Limited to U.S. correctional‑services and government‑contract providers.
Counterpoint
The earnings surge may be unsustainable if federal contracts wane or regulatory pressure increases.
Key entities
- companyCoreCivic, Inc.
U.S. private‑prison operator listed on NYSE under CXW.
- executiveLucibeth Mayberry
President and CEO of CoreCivic.



